CLINICAL_TRIALS
trial_result
· 2020-07-02
Clinical Trial Update: A Rollover Protocol of Dacomitinib For Patients In Japan [Phase 2]
Summary
Phase 2 rollover protocol trial of dacomitinib in Japanese patients with non-small cell lung cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: NSCLC | Phase 2 | Status: COMPLETED | Results posted: 2020-07-02